Seeking Alpha

Acura Pharmaceuticals (ACUR) plummets 32% after news on Friday that Pfizer (PFE) has terminated...

Acura Pharmaceuticals (ACUR) plummets 32% after news on Friday that Pfizer (PFE) has terminated the license to three development-stage drugs that use Acura’s technology.
Comments (2)
  • ronk105
    , contributor
    Comments (3) | Send Message
     
    Once again the media is the blame for so called "mass hysteria". PFE is keeping oxceta, ACUR's drug and is selling and manufacturing as we speak. They merely cancelled three preliminary so called "pipeline" products. People should read before they react.
    30 Jul 2012, 09:55 AM Reply Like
  • richwillard
    , contributor
    Comments (49) | Send Message
     
    So ronk105, the pipeline products were relinquished by PFE, while the only FDA approved drug of the four was kept, correct? Do the three candidate products also use the same technology of delivery? That would seem to add some relevance to the sell off, and undermine their confidence in future prospects for the three candidates don't you think?
    30 Jul 2012, 11:18 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs